![]() Pharmacyclics Pharmacyclics Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. | ![]() HUYA Bioscience International HUYA Bioscience International is a company specializing in the biopharmaceutical products. | ![]() Deciphera Pharmaceuticals Deciphera Pharmaceuticals is a clinical-stage biopharmaceutical company that develops medicines for patients with cancer. | ||
Founding Date | Founding Date 2004 | Founding Date 1991 | Founding Date 2004 | Founding Date 2003 |
Type | Type Private | Type Subsidiary | Type Private | Type Public |
Tags | ||||
Locations | Locations Paris, FR HQ | Locations Sunnyvale, US HQ | Locations San Diego, US HQ Chengdu Shi, CN Guangzhou Shi, CN Hangzhou, CN Shenzhen Shi, CN Shenzhen Shi, CN Suzhou Shi, CN see more | Locations Waltham, US HQ Lawrence, US |
Employees | Employees N/A | Employees 6551% decrease | Employees 1113% increase | Employees 35037% increase |
Financial | ||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $729.7m (FY, 2014) | Revenue (est.) N/A | Revenue (est.) $163.4m (FY, 2023) |
Cost of goods | Cost of goods N/A | Cost of goods $40.4m (FY, 2014) | Cost of goods N/A | Cost of goods $3.7m (FY, 2023) |
Gross profit | Gross profit N/A | Gross profit $689.3m (FY, 2014) | Gross profit N/A | Gross profit $159.6m (FY, 2023) |
Net income | Net income N/A | Net income $86.1m (FY, 2014) | Net income N/A | Net income ($194.9m) (FY, 2023) |
Funding | ||||
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 12.6m | Total funding raised $ 714m |

Pharmacyclics Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases.
View company
HUYA Bioscience International is a company specializing in the biopharmaceutical products.
View company
Deciphera Pharmaceuticals is a clinical-stage biopharmaceutical company that develops medicines for patients with cancer.
View company